Synthesis and Biological Evaluation of 2,4-Diaminopyrimidine-Based Antifolate Drugs against Bacillus anthracis
Due to the innate ability of bacteria to develop resistance to available antibiotics, there is a critical need to develop new agents to treat more resilient strains. As a continuation of our research in this area, we have synthesized a series of racemic 2,4-diaminopyrimidine-based drug candidates,...
Main Authors: | Baskar Nammalwar, N. Prasad Muddala, Christina R. Bourne, Mary Henry, Philip C. Bourne, Richard A. Bunce, Esther W. Barrow, K. Darrell Berlin, William W. Barrow |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/19/3/3231 |
Similar Items
-
Evaluation of New Dihydrophthalazine-Appended 2,4-Diaminopyrimidines against Bacillus anthracis: Improved Syntheses Using a New Pincer Complex
by: Nagendra Prasad Muddala, et al.
Published: (2015-04-01) -
A novel bicyclic 2,4-diaminopyrimidine inhibitor of Streptococcus suis dihydrofolate reductase
by: Warangkhana Songsungthong, et al.
Published: (2021-02-01) -
Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017
by: Kasama Rakmark, et al.
Published: (2020-07-01) -
Type 2 antifolates in the chemotherapy of falciparum malaria
by: Delfino Reinaldo T., et al.
Published: (2002-01-01) -
Factors Influencing the Antifolate Activity of Synthetic Tea-Derived Catechins
by: José Neptuno Rodríguez-López, et al.
Published: (2013-07-01)